Eivind Galteland

Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial

Sigbjørn Berentsen, Ulla Randen, Markku Oksman et al. · Blood · 2017 · 141 citations · Full text

Medicine, Immunology, Internal Medicine +6

Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil

P. De Angelis, Bjørg Fjell, Katherine Kravik et al. · International Journal of Oncology · 2004 · 101 citations

Medicine, Oncology, Pharmacology +15

Loss of chromosome 11q21–23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin’s lymphoma

Trond Stokke, Paula M. DeAngelis, L Smedshammer et al. · British Journal of Cancer · 2001 · 40 citations · Full text

Life Sciences, Hematology, Oncology +15

Translocation t(14;18) and gain of chromosome 18/BCL2: effects on BCL2 expression and apoptosis in B-cell non-Hodgkin's lymphomas

Eivind Galteland, Einar Andreas Sivertsen, Debbie Hege Svendsrud et al. · Leukemia · 2005 · 36 citations

Life Sciences, Genetics, Oncology +11

Oncogenic aberrations in the p53 pathway are associated with a high S phase fraction and poor patient survival in b-cell non-Hodgkin's lymphoma

Trond Stokke, Eivind Galteland, Harald Holte et al. · International Journal of Cancer · 2000 · 27 citations

Life Sciences, Molecular Biology, Oncology +16